Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MaxWin International HoldingsHKSE:08513 53 PB Ratio is 2.81 as of Sep. 17, 2026, which is 39% below its 10-year median of 4.59. GuruFocus rates HKSE:08513 with a GF Score™ of 53/100 and a GF Value™ of HK$1.97 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 785 Medical Devices & Instruments companies, MaxWin International Holdings ranks worse than 61.66% on this metric.
MaxWin International Holdings Ltd stock PB Ratio (=2.86) is close to 2-year low of 2.72.
The historical rank and industry rank for MaxWin International Holdings's PB Ratio or its related term are showing as below:
HKSE:08513'
s PB Ratio Range Over the Past 10 Years
Min: 0.51 Med: 4.59 Max: 25.57
Current: 2.86
During the past 11 years, MaxWin International Holdings's highest PB Ratio was 25.57. The lowest was 0.51. And the median was 4.59.
HKSE:08513's PB Ratio is ranked worse than 61.66% of 785
companies
in the Medical Devices & Instruments industry
Industry Median: 2.11
vs HKSE:08513: 2.86
During the past 12 months, MaxWin International Holdings's average Book Value Per Share Growth Rate was -25.80% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -49.60% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -47.20% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was -7.60% per year.
During the past 11 years, the highest 3-Year average Book Value Per Share Growth Rate of MaxWin International Holdings was 96.30% per year. The lowest was -51.50% per year. And the median was -6.40% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
MaxWin International Holdings PB Ratio Related Terms
MaxWin International Holdings PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, MaxWin International Holdings's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MaxWin International Holdings PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, MaxWin International Holdings's PB Ratio distribution charts can be found below:
* The bar in red indicates where MaxWin International Holdings's PB Ratio falls into.
MaxWin International Holdings PB Ratio Calculation
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
MaxWin International Holdings (HKSE:08513) has a PB Ratio of 2.81 as of Sep. 17, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on MaxWin International Holdings and its competitors. This is 39% below median its historical median of 4.59. Over the past decade, MaxWin International Holdings' PB Ratio has ranged from 0.51 to 25.57. According to the industry distribution chart, MaxWin International Holdings ranks #484 out of 785 companies in the Medical Devices & Instruments industry, placing it in the top 61.7%.
Is MaxWin International Holdings' PB Ratio too high?
MaxWin International Holdings' current PB Ratio of 2.81 is 39% below median its 10-year median of 4.59. Over the past 10 years, this metric has ranged from a low of 0.51 to a high of 25.57. The Medical Devices & Instruments industry median PB Ratio is 2.11. MaxWin International Holdings' value of 2.81 is 33.2% above this industry median. Based on the distribution chart, MaxWin International Holdings ranks #484 out of 785 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, MaxWin International Holdings has a GF Score™ of 53/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does MaxWin International Holdings' PB Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, MaxWin International Holdings ranks #484 out of 785 companies for PB Ratio. This places MaxWin International Holdings in the lower half of its industry. The industry median PB Ratio is 2.11. MaxWin International Holdings' value of 2.81 is 33.2% above this benchmark. Historically, MaxWin International Holdings' own PB Ratio has ranged from 0.51 to 25.57 over the past decade. While the company's 10-year median is 4.59 vs. the industry median of 2.11, MaxWin International Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.11, based on 785 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MaxWin International Holdings's current PB Ratio of 2.81 is 33.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on MaxWin International Holdings and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.11 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MaxWin International Holdings's current PB Ratio is 2.81, which is 39% below median its own 10-year median of 4.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MaxWin International Holdings stock overvalued right now?
Based on GuruFocus' analysis, MaxWin International Holdings (HKSE:08513) is currently considered Possible Value Trap. The stock's GF Value™ is HK$1.97, compared to a current price of HK$0.32 — trading 84% below its estimated fair value. The current PB Ratio is 2.81, which is 39% below median its 10-year median of 4.59 and 33.2% above the Medical Devices & Instruments industry median of 2.11. MaxWin International Holdings' overall GF Score™ is 53/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For MaxWin International Holdings (HKSE:08513), the current PB Ratio is 2.81 as of Sep. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MaxWin International Holdings (HKSE:08513) Overvalued in 2026?
Based on GuruFocus' analysis, MaxWin International Holdings stock appears to be undervalued.
The current stock price of HK$0.32 is trading 84% below its estimated GF Value™ of HK$1.97.
GuruFocus considers MaxWin International Holdings to be Possible Value Trap.
Key valuation signals for HKSE:08513:
PB Ratio: 2.81 (39% below median its 10-year median of 4.59)
GF Value™: HK$1.97 vs. price of HK$0.32 (84% below fair value)
Industry Position: 33.2% above the Medical Devices & Instruments median (#484 of 785)
No single metric tells the full story. See the HKSE:08513 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MaxWin International Holdings Ltd is engaged in the manufacturing and sale of injection molded plastic parts for disposable medical devices and the provision of tooling services in Singapore. The group also operates in data solutions and services involving IT-related products and maintenance services, as well as hospitality operations. It has four reportable segments: Component Parts, Sub-assembly Parts, Data Solutions and Services, and Hospitality. It generates the majority of its revenue from the Component Parts segment. Geographically, it generates the majority of its revenue from Mainland China.
53GF Score
Get the complete analysis for HKSE:08513
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:08513 has been successfully added to your 
